These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17408026)

  • 21. [Hepatitis C virus subverts pattern recognition receptors-mediated control of adaptative immunity orchestrated by dendritic cells].
    Rodrigue-Gervais IG; Lamarre D
    Med Sci (Paris); 2010 Oct; 26(10):869-74. PubMed ID: 20929679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myeloid dendritic cells of patients with chronic HCV infection induce proliferation of regulatory T lymphocytes.
    Dolganiuc A; Paek E; Kodys K; Thomas J; Szabo G
    Gastroenterology; 2008 Dec; 135(6):2119-27. PubMed ID: 18835391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment.
    Urbani S; Amadei B; Tola D; Pedrazzi G; Sacchelli L; Cavallo MC; Orlandini A; Missale G; Ferrari C
    J Hepatol; 2008 Apr; 48(4):548-58. PubMed ID: 18280607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monocyte-derived dendritic cells from HCV-infected patients transduced with an adenovirus expressing NS3 are functional when stimulated with the TLR3 ligand poly(I:C).
    Echeverría I; Zabaleta A; Silva L; Díaz-Valdés N; Riezu-Boj JI; Lasarte JJ; Borrás-Cuesta F; Civeira MP; Prieto J; Sarobe P
    J Viral Hepat; 2008 Nov; 15(11):782-9. PubMed ID: 18637068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV interactions with dendritic cells: has our focus been too narrow?
    Donaghy H; Wilkinson J; Cunningham AL
    J Leukoc Biol; 2006 Nov; 80(5):1001-12. PubMed ID: 16923917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV and cells of macrophage/dendritic lineage and other non-T cell reservoirs: new answers yield new questions.
    Collman RG; Perno CF; Crowe SM; Stevenson M; Montaner LJ
    J Leukoc Biol; 2003 Nov; 74(5):631-4. PubMed ID: 12960251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early triggering of exclusive IFN-gamma responses of human Vgamma9Vdelta2 T cells by TLR-activated myeloid and plasmacytoid dendritic cells.
    Devilder MC; Allain S; Dousset C; Bonneville M; Scotet E
    J Immunol; 2009 Sep; 183(6):3625-33. PubMed ID: 19710464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of innate immune responses in autoimmune disease development.
    Waldner H
    Autoimmun Rev; 2009 Mar; 8(5):400-4. PubMed ID: 19162250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complement-HIV interactions during all steps of viral pathogenesis.
    Stoiber H; Banki Z; Wilflingseder D; Dierich MP
    Vaccine; 2008 Jun; 26(24):3046-54. PubMed ID: 18191309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Consequences of the natural propensity of Leishmania and HIV-1 to target dendritic cells.
    Garg R; Trudel N; Tremblay MJ
    Trends Parasitol; 2007 Jul; 23(7):317-24. PubMed ID: 17531536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired TRAIL-dependent cytotoxicity of CD1c-positive dendritic cells in chronic hepatitis C virus infection.
    Ciesek S; Liermann H; Hadem J; Greten T; Tillmann HL; Cornberg M; Aslan N; Manns MP; Wedemeyer H
    J Viral Hepat; 2008 Mar; 15(3):200-11. PubMed ID: 18233993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fiber-modified recombinant adenoviral constructs encoding hepatitis C virus proteins induce potent HCV-specific T cell response.
    Thammanichanond D; Moneer S; Yotnda P; Aitken C; Earnest-Silveira L; Jackson D; Hellard M; McCluskey J; Torresi J; Bharadwaj M
    Clin Immunol; 2008 Sep; 128(3):329-39. PubMed ID: 18524682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stable recovery from HCV in HIV-HCV co-infection under antiretroviral therapy.
    Zeitoun JD; Mallet V; Chaix ML; Viard JP; Blanche S; Pol S
    J Clin Virol; 2007 Sep; 40(1):71-3. PubMed ID: 17658294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct susceptibility of dendritic cell subsets to hepatitis C virus infection: a plausible mechanism of dendritic cell dysfunction.
    Kanto T; Hayashi N
    J Gastroenterol; 2004 Aug; 39(8):811-2. PubMed ID: 15338382
    [No Abstract]   [Full Text] [Related]  

  • 35. Pathogenesis of liver damage in HCV-HIV patients.
    Bruno R; Sacchi P; Puoti M; Maiocchi L; Patruno SF; Cima S; Filice G
    AIDS Rev; 2008; 10(1):15-24. PubMed ID: 18385777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunological determinants of the outcomes from primary hepatitis C infection.
    Post J; Ratnarajah S; Lloyd AR
    Cell Mol Life Sci; 2009 Mar; 66(5):733-56. PubMed ID: 19011759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C virus structural proteins do not prevent human dendritic cell maturation.
    Thumann C; Schvoerer E; Abraham JD; Bohbot A; Stoll-Keller F; Aubertin AM; Kieny MP
    Gastroenterol Clin Biol; 2008 Jan; 32(1 Pt. 1):59-68. PubMed ID: 18341978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C virus core protein impairs in vitro priming of specific T cell responses by dendritic cells and hepatocytes.
    Zimmermann M; Flechsig C; La Monica N; Tripodi M; Adler G; Dikopoulos N
    J Hepatol; 2008 Jan; 48(1):51-60. PubMed ID: 17998148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunology of hepatitis B and hepatitis C virus infections.
    Boonstra A; Woltman AM; Janssen HL
    Best Pract Res Clin Gastroenterol; 2008; 22(6):1049-61. PubMed ID: 19187866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the relationship between cytokine secretion and proliferative capacity in hepatitis C virus infection.
    Semmo N; Krashias G; Willberg C; Klenerman P
    J Viral Hepat; 2007 Jul; 14(7):492-502. PubMed ID: 17576391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.